5csf - Revision history

OCA at 11:45, 9 May 2024

2024-05-09T11:45:40Z

← Older revision		Revision as of 11:45, 9 May 2024
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[5csf]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CSF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5CSF FirstGlance]. <br>		<table><tr><td colspan='2'>[[5csf]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CSF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5CSF FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>		</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.4Å</td></tr>
			<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5csf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5csf OCA], [https://pdbe.org/5csf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5csf RCSB], [https://www.ebi.ac.uk/pdbsum/5csf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5csf ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5csf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5csf OCA], [https://pdbe.org/5csf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5csf RCSB], [https://www.ebi.ac.uk/pdbsum/5csf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5csf ProSAT]</span></td></tr>
	</table>		</table>
Line 20:		Line 21:

	==See Also==		==See Also==
	*[[Ribosomal protein S6 kinase\|Ribosomal protein S6 kinase]]
	*[[S100 proteins 3D structures\|S100 proteins 3D structures]]		*[[S100 proteins 3D structures\|S100 proteins 3D structures]]
	== References ==		== References ==

OCA at 12:26, 14 June 2023

2023-06-14T12:26:01Z

← Older revision		Revision as of 12:26, 14 June 2023
Line 1:		Line 1:

	==S100B-RSK1 crystal structure A==		==S100B-RSK1 crystal structure A==
	<StructureSection load='5csf' size='340' side='right' caption='[[5csf]], [[Resolution\|resolution]] 2.40Å' scene=''>		<StructureSection load='5csf' size='340' side='right'caption='[[5csf]], [[Resolution\|resolution]] 2.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[5csf]] is a 3 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CSF OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5CSF FirstGlance]. <br>		<table><tr><td colspan='2'>[[5csf]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CSF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5CSF FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene~~></td></tr>~~		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">S100B ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN]), RPS6KA1, MAPKAPK1A, RSK1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5csf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5csf OCA], [https://pdbe.org/5csf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5csf RCSB], [https://www.ebi.ac.uk/pdbsum/5csf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5csf ProSAT]</span></td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5csf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5csf OCA], [~~http~~://pdbe.org/5csf PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5csf RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5csf PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5csf ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
	[~~[http~~://www.uniprot.org/uniprot/S100B_HUMAN S100B_HUMAN]] Weakly binds calcium but binds zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Physiological concentrations of potassium ion antagonize the binding of both divalent cations, especially affecting high-affinity calcium-binding sites. Binds to and initiates the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling (By similarity). Could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization.<ref>PMID:20351179</ref> [[http://www.uniprot.org/uniprot/KS6A1_HUMAN KS6A1_HUMAN]] Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression.<ref>PMID:9430688</ref> <ref>PMID:10679322</ref> <ref>PMID:11684016</ref> <ref>PMID:12213813</ref> <ref>PMID:15117958</ref> <ref>PMID:15342917</ref> <ref>PMID:16213824</ref> <ref>PMID:16223362</ref> <ref>PMID:16763566</ref> <ref>PMID:17360704</ref> <ref>PMID:18722121</ref>		[https://www.uniprot.org/uniprot/S100B_HUMAN S100B_HUMAN] Weakly binds calcium but binds zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Physiological concentrations of potassium ion antagonize the binding of both divalent cations, especially affecting high-affinity calcium-binding sites. Binds to and initiates the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling (By similarity). Could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization.<ref>PMID:20351179</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 20:		Line 18:
	</div>		</div>
	<div class="pdbe-citations 5csf" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 5csf" style="background-color:#fffaf0;"></div>

			==See Also==
			*[[Ribosomal protein S6 kinase\|Ribosomal protein S6 kinase]]
			*[[S100 proteins 3D structures\|S100 proteins 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
	[[Category: ~~Human~~]]		[[Category: Homo sapiens]]
	[[Category: ~~Non-specific serine/threonine protein kinase~~]]		[[Category: Large Structures]]
	[[Category: Gogl, G]]		[[Category: Gogl G]]
	[[Category: Nyitray, L]]		[[Category: Nyitray L]]
	~~[[Category: Complex]]~~
	~~[[Category: Inhibitor]]~~
	~~[[Category: Kinase]]~~
	~~[[Category: Signaling]]~~
	~~[[Category: Transferase~~]]

OCA at 14:03, 16 November 2017

2017-11-16T14:03:07Z

← Older revision		Revision as of 14:03, 16 November 2017
Line 1:		Line 1:

	==S100B-RSK1 crystal structure A==		==S100B-RSK1 crystal structure A==
	<StructureSection load='5csf' size='340' side='right' caption='[[5csf]], [[Resolution\|resolution]] 2.40Å' scene=''>		<StructureSection load='5csf' size='340' side='right' caption='[[5csf]], [[Resolution\|resolution]] 2.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[5csf]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CSF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5CSF FirstGlance]. <br>		<table><tr><td colspan='2'>[[5csf]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CSF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5CSF FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
			<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">S100B ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN]), RPS6KA1, MAPKAPK1A, RSK1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5csf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5csf OCA], [http://pdbe.org/5csf PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5csf RCSB], [http://www.ebi.ac.uk/pdbsum/5csf PDBsum]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5csf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5csf OCA], [http://pdbe.org/5csf PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5csf RCSB], [http://www.ebi.ac.uk/pdbsum/5csf PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5csf ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 22:		Line 24:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
			[[Category: Human]]
	[[Category: Non-specific serine/threonine protein kinase]]		[[Category: Non-specific serine/threonine protein kinase]]
	[[Category: Gogl, G]]		[[Category: Gogl, G]]

OCA at 18:47, 30 November 2015

2015-11-30T18:47:53Z

← Older revision		Revision as of 18:47, 30 November 2015
Line 1:		Line 1:
	'''~~Unreleased~~ structure'''		==S100B-RSK1 crystal structure A==
			<StructureSection load='5csf' size='340' side='right' caption='[[5csf]], [[Resolution\|resolution]] 2.40Å' scene=''>
			== Structural highlights ==
			<table><tr><td colspan='2'>[[5csf]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CSF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5CSF FirstGlance]. <br>
			</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
			<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr>
			<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5csf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5csf OCA], [http://pdbe.org/5csf PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5csf RCSB], [http://www.ebi.ac.uk/pdbsum/5csf PDBsum]</span></td></tr>
			</table>
			== Function ==
			[[http://www.uniprot.org/uniprot/S100B_HUMAN S100B_HUMAN]] Weakly binds calcium but binds zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Physiological concentrations of potassium ion antagonize the binding of both divalent cations, especially affecting high-affinity calcium-binding sites. Binds to and initiates the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling (By similarity). Could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization.<ref>PMID:20351179</ref> [[http://www.uniprot.org/uniprot/KS6A1_HUMAN KS6A1_HUMAN]] Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression.<ref>PMID:9430688</ref> <ref>PMID:10679322</ref> <ref>PMID:11684016</ref> <ref>PMID:12213813</ref> <ref>PMID:15117958</ref> <ref>PMID:15342917</ref> <ref>PMID:16213824</ref> <ref>PMID:16223362</ref> <ref>PMID:16763566</ref> <ref>PMID:17360704</ref> <ref>PMID:18722121</ref>
			<div style="background-color:#fffaf0;">
			== Publication Abstract from PubMed ==
			Mitogen-activated protein kinases (MAPK) promote MAPK activated protein kinase (MAPKAPK) activation. In the MAPK pathway responsible to cell growth, ERK2 initiates the first phosphorylation event on RSK1, which is inhibited by calcium-binding S100 proteins in malignant melanomas. Here we present a detailed in vitro biochemical and structural characterization of the S100B-RSK1 interaction. The calcium-dependent binding of S100B to the calcium/calmodulin dependent protein kinase (CaMK)-type domain of RSK1 is reminiscent to the better known binding of calmodulin to CaMKII. Although S100B-RSK1 and the calmodulin-CAMKII system are clearly distinct functionally, they demonstrate how unrelated intracellular Ca2+ binding proteins could influence the activity of CaMK domain containing protein kinases. Our crystallographic, small angle X-ray scattering (SAXS) and NMR analysis revealed that S100B forms a ''fuzzy'' complex with RSK1 peptide ligands. Based on fast-kinetics experiments we conclude that the binding involves both conformation selection and induced fit steps. Knowledge of the structural basis of this interaction could facilitate therapeutic targeting of melanomas.

	~~The entry 5csf is ON HOLD until Paper Publication~~		Structural basis of Ribosomal S6 Kinase 1 (RSK1) inhibition by S100B Protein: modulation of the Extracellular Signal-regulated Kinase (ERK) signaling cascade in a calcium-dependent way.,Gogl G, Alexa A, Kiss B, Katona G, Kovacs M, Bodor A, Remenyi A, Nyitray L J Biol Chem. 2015 Nov 2. pii: jbc.M115.684928. PMID:26527685<ref>PMID:26527685</ref>

	~~Authors: Gogl~~, G.~~, Nyitray, L~~.		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
			</div>
	~~Description~~: ~~S100B-RSK1 crystal structure A~~		<div class="pdbe-citations 5csf" style="background-color:#fffaf0;"></div>
	[[Category: ~~Unreleased Structures~~]]		== References ==
			<references/>
			__TOC__
			</StructureSection>
			[[Category: Non-specific serine/threonine protein kinase]]
	[[Category: Gogl, G]]		[[Category: Gogl, G]]
	[[Category: Nyitray, L]]		[[Category: Nyitray, L]]
			[[Category: Complex]]
			[[Category: Inhibitor]]
			[[Category: Kinase]]
			[[Category: Signaling]]
			[[Category: Transferase]]

OCA at 13:25, 12 August 2015

2015-08-12T13:25:46Z

← Older revision		Revision as of 13:25, 12 August 2015
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

	The entry 5csf is ON HOLD		The entry 5csf is ON HOLD until Paper Publication

	Authors: Gogl, G., Nyitray, L.		Authors: Gogl, G., Nyitray, L.

OCA: Protected "5csf" [edit=sysop:move=sysop]

2015-07-29T13:49:42Z

Protected "5csf" [edit=sysop:move=sysop]

← Older revision	Revision as of 13:49, 29 July 2015
(No difference)

OCA: New page: '''Unreleased structure''' The entry 5csf is ON HOLD Authors: Gogl, G., Nyitray, L. Description: S100B-RSK1 crystal structure A Category: Unreleased Structures [[Category: Gogl, G]...

2015-07-29T13:49:41Z

New page: '''Unreleased structure''' The entry 5csf is ON HOLD Authors: Gogl, G., Nyitray, L. Description: S100B-RSK1 crystal structure A Category: Unreleased Structures [[Category: Gogl, G]...

New page

'''Unreleased structure'''

The entry 5csf is ON HOLD

Authors: Gogl, G., Nyitray, L.

Description: S100B-RSK1 crystal structure A
[[Category: Unreleased Structures]]
[[Category: Gogl, G]]
[[Category: Nyitray, L]]